[{"address1": "900 Middlefield Road", "address2": "4th Floor", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 980 9099", "website": "https://biomeafusion.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.", "fullTimeEmployees": 110, "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 2, "previousClose": 5.19, "open": 5.15, "dayLow": 5.08, "dayHigh": 5.5, "regularMarketPreviousClose": 5.19, "regularMarketOpen": 5.15, "regularMarketDayLow": 5.08, "regularMarketDayHigh": 5.5, "beta": -0.374, "forwardPE": -1.5290698, "volume": 6842347, "regularMarketVolume": 6842347, "averageVolume": 1383032, "averageVolume10days": 4172670, "averageDailyVolume10Day": 4172670, "bid": 5.2, "ask": 5.26, "bidSize": 600, "askSize": 900, "marketCap": 189068608, "fiftyTwoWeekLow": 3.61, "fiftyTwoWeekHigh": 33.0, "fiftyDayAverage": 10.2122, "twoHundredDayAverage": 13.265875, "currency": "USD", "enterpriseValue": 55242512, "floatShares": 19449974, "sharesOutstanding": 35944600, "sharesShort": 13138112, "sharesShortPriorMonth": 13818949, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.3655, "heldPercentInsiders": 0.25144, "heldPercentInstitutions": 0.87124, "shortRatio": 17.7, "shortPercentOfFloat": 0.5982, "impliedSharesOutstanding": 35944600, "bookValue": 3.766, "priceToBook": 1.3967074, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -127265000, "trailingEps": -3.55, "forwardEps": -3.44, "enterpriseToEbitda": -0.408, "52WeekChange": -0.78455865, "SandP52WeekChange": 0.26238096, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "BMEA", "underlyingSymbol": "BMEA", "shortName": "Biomea Fusion, Inc.", "longName": "Biomea Fusion, Inc.", "firstTradeDateEpochUtc": 1618579800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "bc0a49f6-c4ed-3d62-b67c-2f5f0de07165", "messageBoardId": "finmb_695310535", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.26, "targetHighPrice": 60.0, "targetLowPrice": 5.0, "targetMeanPrice": 31.83, "targetMedianPrice": 33.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 144918000, "totalCashPerShare": 4.032, "ebitda": -135520992, "totalDebt": 11092000, "quickRatio": 5.738, "currentRatio": 5.843, "debtToEquity": 8.197, "returnOnAssets": -0.60987, "returnOnEquity": -1.1652, "freeCashflow": -62755876, "operatingCashflow": -104578000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]